Alpha Cognition Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
Supporting Evidence:
The company stated in the following press release that they use animals for product testing.
“These outcomes are in agreement with those of an earlier pre-clinical study in a moderate TBI animal model, both studies demonstrated protective effects of ALPHA-1062, providing support for the continued development of ALPHA-1062 for the treatment of traumatic brain injury” said Denis Kay, ACI’s Chief Scientific Officer. Read the following article
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company’s commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer’s disease. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Company Website: https://www.alphacognition.com